Olaf Grip

Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial

M. Parkes, J. Satsangi, Fraser Cummings, 2023, The lancet. Gastroenterology & hepatology.